Diversity of GMP compliant platforms for the manufacturing of biotherapeutics
Our team has experience in both microbial and mammalian cell line development using established, efficient, and GMP compliant platforms:
- E. coli
- P. pastoris
- CHO-K1, CHO-S (available in 2020)
Focused on the success of your project, we will suggest the most appropriate expression platform based on the nature of your protein and your IP constraints. In addition, we adapt our cell line development services to include tailored product quality analysis at key points of the process and ensure that your critical product attributes targets are met.
Integrated process development services to support biotherapeutics development projects
Our cell line development services can be used as stand-alone services but are more often integrated into larger process development programmes including upstream & downstream process development and the development of supporting analytical methods.
Our solid know-how based on 19 years’ track record developing processes for challenging proteins is a great asset to the success of your project. Our expert process development team will always focus on developing the best process for your specific molecule, in addition to providing valuable flexibility and guidance through your project.
